EUVIMEDEUVIMED entdecken
Open Access

Impaired Awareness and Symptomatology of Hypoglycemia in Adults With Type 1 Diabetes Using Continuous Glucose Monitoring

Yu Kuei Lin iD, Wen Ye, Emily Hepworth, Michael R Rickels, Stephanie A Amiel, Jane Speight, James A M Shaw

The Journal of Clinical Endocrinology & Metabolism · 15.07.2025 · 110 (8) · e2553-e2561

DOI: 10.1210/clinem/dgae846 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, online erschienen am 05.12.2024. Verfasst von Yu Kuei Lin und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI 48105, USA. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Hypoglycemia, Blood Glucose Self-Monitoring, Awareness. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NCATS NIH HHS, Michigan Center for Clinical and Translational Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context and Objective Sparse large-scale studies have characterized hypoglycemia symptomatology in adults with type 1 diabetes (T1D) who use continuous glucose monitoring (CGM). This research aimed to evaluate the relationship of impaired awareness of hypoglycemia (IAH) with hypoglycemia symptomatology and frequency in this population.

Design

A cross-sectional survey was conducted in 2023. HypoA-Q was used to evaluate hypoglycemia frequency, symptomatology, and awareness. Setting & Participants Registrants who used CGM in the T1D Exchange, a U.S. national T1D registry.

Results

Surveys were completed by 1480 adults with T1D who used CGM (53% female; mean diabetes duration 26 years). Compared to those with intact hypoglycemia awareness, IAH was associated with less frequent hypoglycemia symptom presentation across various glucose levels and lower glucose concentrations for first presenting hypoglycemia symptoms when awake (P < .05 for all). More than 70% of individuals with IAH did not regularly experience symptoms during episodes with glucose <54 mg/dL. When asleep, those with IAH were less frequently awoken by symptoms, more frequently awoken by others who recognized their hypoglycemia, and more frequently acknowledged hypoglycemia after an episode (P < .05 for all) despite using CGM. With reduced symptoms, both when awake and asleep, those with IAH experienced more hypoglycemic episodes that they were unable to self-treat than those with intact awareness (P < .05).

Conclusion

IAH continues to be associated with a significant reduction in detection of hypoglycemia symptoms, both when awake and asleep, in adults using CGM. Current diabetes technologies do not fully protect adults with T1D from hypoglycemia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 1HypoglycemiaBlood Glucose Self-MonitoringAwarenessHumansFemaleAdultCross-Sectional StudiesMaleMiddle AgedBlood GlucoseYoung AdultHypoglycemic AgentsRegistriesContinuous Glucose Monitoring

Stichwörter der Autor:innen

continuous glucose monitorshypoglycemiahypoglycemia symptomatologyimpaired awareness of hypoglycemiatype 1 diabetes

Substanzen

Blood GlucoseHypoglycemic Agents

Autor:innen und Institutionen

  • Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI 48105, USA.
  • Department of Biostatistics, University of Michigan School of Public Health, Ann Arbor, MI 48109, USA.
  • Department of Medicine, Division of Endocrinology, Diabetes & Metabolism, and Institute for Diabetes, Obesity & Metabolism, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA.
  • Department of Diabetes, School of Cardiovascular and Metabolic Medicine and Sciences, Kings College London, London SE5 9RJ, UK.
  • School of Psychology, Institute for Health Transformation, Faculty of Health, Deakin University, Geelong, VIC 3125, Australia.
  • The Australian Centre for Behavioural Research in Diabetes, Diabetes Victoria, Carlton, VIC 3051, Australia.

ORCID-Profile: Yu Kuei Lin

Förderung

  • NIDDK NIH HHS
  • NCATS NIH HHS
  • Michigan Center for Clinical and Translational Research
  • National Institute of Diabetes and Digestive and Kidney Diseases
  • NCATS

Zitieren

APA

Lin, Y. K., Ye, W., Hepworth, E., Rickels, M. R., Amiel, S. A., Speight, J., & Shaw, J. A. M. (2025). Impaired Awareness and Symptomatology of Hypoglycemia in Adults With Type 1 Diabetes Using Continuous Glucose Monitoring. The Journal of Clinical Endocrinology & Metabolism, 110(8), e2553-e2561. https://doi.org/10.1210/clinem/dgae846

Vancouver

Lin YK, Ye W, Hepworth E, Rickels MR, Amiel SA, Speight J, et al. Impaired Awareness and Symptomatology of Hypoglycemia in Adults With Type 1 Diabetes Using Continuous Glucose Monitoring. The Journal of Clinical Endocrinology & Metabolism. 2025;110(8):e2553-e2561. doi:10.1210/clinem/dgae846

BibTeX
@article{Lin2025,
  author = {Lin, Yu Kuei and Ye, Wen and Hepworth, Emily and Rickels, Michael R and Amiel, Stephanie A and Speight, Jane and Shaw, James A M},
  title = {Impaired Awareness and Symptomatology of Hypoglycemia in Adults With Type 1 Diabetes Using Continuous Glucose Monitoring},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2025},
  volume = {110},
  number = {8},
  pages = {e2553--e2561},
  doi = {10.1210/clinem/dgae846}
}
Kostenlos starten →